Epitope characterization of anti-drug antibodies—a tool for discovery and health: an overview of the necessity of early epitope characterization to avoid anti-drug antibodies and promote patient health-Reference-Cited by-同舟云学术

Epitope characterization of anti-drug antibodies—a tool for discovery and health: an overview of the necessity of early epitope characterization to avoid anti-drug antibodies and promote patient health

Published:2021-01-25 Issue: Volume: Page:1-11
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

McMaster Matthew¹,Mohr Kelly¹,Page Austin²,Closmore Adam³,Towne Francina¹,Brooks Benjamin D.²

Affiliation:

1. Department of Biomedical Sciences, Rocky Vista University, Parker, CO, USA

2. Department of Biomedical Sciences, Rocky Vista University, Ivins, UT, USA

3. Department of Pharmacy, North Dakota State University, Fargo, ND, USA

Funder

Foundation for the National Institutes of Health

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1863942

Reference42 articles.

1. Monoclonal antibodies (mAbs) market size | industry report, 2013–2024. [Cited 2016 Nov 12]. Available from: http://www.grandviewresearch.com/industry-analysis/monoclonal-antibodies-market

2. Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges

3. Antibody Therapeutics in Cancer

4. Protein therapeutics: a summary and pharmacological classification

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy, and Immunogenicity of a Novel IgG Degrading Enzyme (KJ103): Results from Two Randomised, Blinded, Phase 1 Clinical Trials;2024-05-30

2. Whole protein or long peptides in therapeutic vaccination strategies, does it make a difference?;Expert Opinion on Biological Therapy;2022-12-09

3. Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics;Pharmaceutics;2022-12-01

4. Evaluation of the potential immunogenicity of recombinant human bone morphogenetic proteins;Ural Medical Journal;2022-11-05

5. 2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (Part 3– Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization);Bioanalysis;2022-06